|
|
|
Volumn 22, Issue 6 SUPPL. 15, 1995, Pages 29-33
|
|
Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: Preliminary results
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALIZAPRIDE;
ANTIEMETIC AGENT;
ANTIHISTAMINIC AGENT;
CHLORPHENIRAMINE;
CIMETIDINE;
CISPLATIN;
CORTICOSTEROID;
CYTOTOXIC AGENT;
DEXAMETHASONE;
DITERPENE;
ETOPOSIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
HISTAMINE H2 RECEPTOR ANTAGONIST;
METHYLPREDNISOLONE;
MITOMYCIN;
NAVELBINE;
ONDANSETRON;
PACLITAXEL;
PROMETHAZINE;
VINBLASTINE;
VINCA ALKALOID;
VINDESINE;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG HYPERSENSITIVITY;
DRUG TOLERANCE;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HISTOLOGY;
HUMAN;
HUMAN TISSUE;
INTRAVENOUS DRUG ADMINISTRATION;
LARGE CELL CARCINOMA;
LUNG ADENOCARCINOMA;
LUNG NON SMALL CELL CANCER;
LUNG SQUAMOUS CELL CARCINOMA;
MALE;
MAXIMUM PERMISSIBLE DOSE;
NEUROTOXICITY;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOCYTOPENIA;
ADENOCARCINOMA;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AXONS;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEASIBILITY STUDIES;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
NEUTROPENIA;
PACLITAXEL;
PERIPHERAL NERVOUS SYSTEM DISEASES;
REMISSION INDUCTION;
|
|
EID: 0029614674
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (22)
|
|
References (0)
|
